SCHEMBL7328438

SCHEMBL7328438

CCn1ncc2c(Cl)c3cc(SC)ccc3nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 4/20 0.43
DAPK3 O43293 1/20 0.43
DYRK3 O43781 1/20 0.43
MAP4K4 O95819 1/20 0.43
CDK1 P06493 1/20 0.43
CDK2 P24941 1/20 0.43
CSNK1A1 P48729 1/20 0.43
CLK2 P49760 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
IRAK1 P51617 1/20 0.43
MAPK12 P53778 1/20 0.43
CSNK2A1 P68400 1/20 0.43
PRKAA1 Q13131 1/20 0.43
PIM3 Q86V86 1/20 0.43
BRSK1 Q8TDC3 1/20 0.43
AURKB Q96GD4 1/20 0.43
HIPK2 Q9H2X6 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
DYRK4 Q9NR20 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7328414 0.82 RXFP1 (0.50) NR3C1ADORA1ADORA3ADORA2APGR
SCHEMBL7330632 0.80 PDE1A (0.44) PDE4BPDE10AMAPTNPSR1
SCHEMBL7332532 0.78 MAOA (0.50) NR3C1ADORA1ADORA3ADORA2APDE10A
SCHEMBL7332950 0.78 ADORA2A (0.38) NR3C1ADORA1ADORA3ADORA2APGR
SCHEMBL7337974 0.78 ADORA3 (0.36) NR3C1ADORA1ADORA3ADORA2APGR
SCHEMBL7330374 0.77 KMT2A (0.47)
SCHEMBL7332575 0.75 NPC1 (0.48) NR3C1MAPTNPSR1
SCHEMBL7428137 0.75 NR3C1 (0.46) NR3C1ADORA1ADORA3ADORA2APGR
SCHEMBL7330944 0.74 LMNA (0.44) NR3C1ADORA1ADORA3ADORA2APGR
SCHEMBL7338059 0.74 PDE10A (0.56) PDE5APDE10AMAPTTSHRRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5942520-A Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines CELL PATHWAYS, INC. (US) 1999-08-24 US disclosed
US-5488055-A ADMINISTERING GMP HOSPHODIESTERASE INHIBITORS FOR TREATMENT OF CONGESTIVE HEART FAILURE AND CARDIOVASCULAR DISORDERS SANOFI WINTHROP INC. (US) 1996-01-30 US disclosed